A multicentre randomised, double-blind, parallel-group study to compare the salmeterol/fluticasone propionate combination (Seretidetm Diskus 50/100) 50/100microg one inhalation twice daily with fluticasone propionate (Flixotide Diskus 100) 100microg one inhalation twice daily as initial maintenance therapy for 12 weeks in adults with persistent moderate asthma.

Trial Profile

A multicentre randomised, double-blind, parallel-group study to compare the salmeterol/fluticasone propionate combination (Seretidetm Diskus 50/100) 50/100microg one inhalation twice daily with fluticasone propionate (Flixotide Diskus 100) 100microg one inhalation twice daily as initial maintenance therapy for 12 weeks in adults with persistent moderate asthma.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Mar 2017

At a glance

  • Drugs Fluticasone propionate; Salmeterol/fluticasone propionate
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms Mechanistic Study
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 22 Mar 2012 Actual patient number 81 added as reported by ClinicalTrials.gov.
    • 14 Oct 2008 Status changed from discontinued to completed.
    • 15 Jan 2008 Status changed from recruiting to discontinued.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top